These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 22096931)
21. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications]. Lange CM; Sarrazin C; Zeuzem S Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084 [No Abstract] [Full Text] [Related]
22. [New triple therapy in chronic hepatitis C. Increased patient chances]. Stiefelhagen P MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830 [No Abstract] [Full Text] [Related]
23. [Treatment for chronic hepatitis C, more opportunity, more challenge]. Wei L Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676 [No Abstract] [Full Text] [Related]
24. Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients. Peres-da-Silva A; de Almeida AJ; Lampe E Arch Virol; 2010 May; 155(5):807-11. PubMed ID: 20405151 [TBL] [Abstract][Full Text] [Related]
25. Current and future management of chronic hepatitis C infection. Cross TJ; Antoniades CG; Harrison PM Postgrad Med J; 2008 Apr; 84(990):172-6. PubMed ID: 18424572 [TBL] [Abstract][Full Text] [Related]
27. Novel approaches for therapy of chronic hepatitis C. Stauber RE; Stadlbauer V J Clin Virol; 2006 Jun; 36(2):87-94. PubMed ID: 16546442 [TBL] [Abstract][Full Text] [Related]
28. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination]. Niederau C MMW Fortschr Med; 2008 Mar; 150(13):26. PubMed ID: 18522352 [No Abstract] [Full Text] [Related]
29. [Perspectives in hepatology in the next 2-3 years: what will be clinically relevant? Viral hepatitis]. Friedrich-Rust M; Forestier N; Zeuzem S Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S229-30. PubMed ID: 16435720 [No Abstract] [Full Text] [Related]
30. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells. Lin K; Kwong AD; Lin C Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857 [TBL] [Abstract][Full Text] [Related]